Earnings Data
Report Date
Aug 10, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.19Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a strong operational and financial improvement story: very large revenue and adjusted-EBITDA gains in the Insurance Distribution segment, narrower GAAP losses, premium growth and loss-ratio improvement at Everspan on a pro forma basis, cost reductions, expanded capacity, and continued strategic progress on platform and AI initiatives. The quarter did include notable one-off headwinds — primarily a litigation settlement and related legal costs that materially inflated reported loss ratios, early-stage losses from newly launched MGAs, and ongoing non-recurring charges — but management quantified these items and highlighted pro forma metrics showing more normalized performance. On balance, the positive operational momentum and material improvements in non‑GAAP profitability and margins significantly outweigh the quarter’s lowlights.Company Guidance
Insurance Distribution Revenue Surge
Total revenues for the Insurance Distribution segment grew 92% year-over-year to $78.5 million in Q1 2026, driven by organic growth of 42% and the October 2025 acquisition of ArmadaCare.
Insurance Distribution Profitability Expansion
Adjusted EBITDA for the Insurance Distribution segment increased nearly fourfold to about $25 million, with adjusted EBITDA margins expanding to ~32% versus 17% a year ago.
Material Improvement in Consolidated Non-GAAP Earnings
Consolidated adjusted EBITDA to shareholders rose to $20.1 million from negative $1.3 million in Q1 2025 (improvement of ~$21.4 million). Consolidated adjusted net income to shareholders was $16.6 million, or $0.37 per share, versus a net loss of $6.0 million a year ago (improvement of $22.6 million).
Narrowing of GAAP Net Loss
Reported net loss to shareholders narrowed to $6.9 million, or $0.13 per share, in Q1 2026 from a net loss of $16.1 million, or $0.57 per share, in Q1 2025 — an improvement of 57%.
Everspan Premium Growth and Loss-Ratio Improvement
Everspan gross premiums written increased 19% to $104 million; net premiums written rose 80% to $32 million and earned premiums increased 28% to $20 million. Accident year loss ratio improved to 54% (active programs ~57%).
Corporate Expense Reduction Progress
Reported corporate expenses declined to just over $12 million from $15 million year-over-year; adjusted corporate expenses fell to $7.2 million from $10.6 million, reflecting cost reduction initiatives.
Balance Sheet / Capacity and Financing
Insurance distribution pro forma net debt-to-EBITDA on a TTM basis was ~3.2x at March 31, 2026. Bank facilities feature five-year tenors and an initial spread of 275 bps over SOFR (which steps down with leverage). Third‑party capacity increased from $1.5 billion entering 2026 to over $2 billion.
Strategic M&A and Capital Deployment
Completed buy-ins acquiring an additional 10% of Octave Ventures and stakes in four other MGAs for ~$44 million (funded with cash and expansion of the term loan). ArmadaCare itself grew revenue organically by ~10% versus its prior-year quarter.
Platform & AI Strategy
Company reiterated a clear strategy transitioning to a scalable MGA platform, with a two-track AI approach (proprietary systems and curated partners), selection of Anthropic as a core AI solution, and consolidation of MGAs on a homogeneous tech stack to accelerate data/AI benefits.
Strong Q1 Seasonality and Positive Outlook
Management characterized Q1 as a strong quarter, ahead of initial plan, and noted momentum with guidance unchanged for now and potential future adjustments; expects 1-2 new MGA startups in 2026 given deliberate selectivity.
DE:FGPN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:FGPN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | €3.44 | €4.80 | +39.53% |
Feb 23, 2026 | €4.62 | €4.52 | -2.16% |
Nov 10, 2025 | €7.30 | €7.50 | +2.74% |
Aug 07, 2025 | €7.30 | €7.10 | -2.74% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Octave Specialty Group (DE:FGPN) report earnings?
Octave Specialty Group (DE:FGPN) is schdueled to report earning on Aug 10, 2026, After Close (Confirmed).
What is Octave Specialty Group (DE:FGPN) earnings time?
Octave Specialty Group (DE:FGPN) earnings time is at Aug 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Octave Specialty Group stock?
The P/E ratio of Octave Specialty Group is N/A.
What is DE:FGPN EPS forecast?
DE:FGPN EPS forecast for the fiscal quarter 2026 (Q2) is >-0.01.